Second-line treatment options in advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Second-line treatment options in advanced non-small cell lung cancer

Published:2011-09 Issue: Volume:47 Page:S258-S271
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

de Marinis Filippo,Ricciardi Serena

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference80 articles.

1. Cancer statistics 2000;Grenlee;CA Cancer J Clin,2000

2. Screening, diagnosis and staging of lung cancer;Shepherd;Curr Opin Oncol,1993

3. Chemotherapy for advanced non small cell lung cancer;Wailing;Respir Med,1994

4. Cancer statistics, 2005;Jemal;CA Cancer J Clin,2005

5. New chemotherapeutic agents prolong survival and improve quality of life in non small cell lung cancer: a review of the literature ad future directions;Bunn;Clin Cancer Res,1998

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second-line Erlotinib or Intermittent Erlotinib plus Docetaxel in Male Ex-smokers with Squamous NSCLC: The TALISMAN Randomized Trial;Anticancer Research;2016-12-01

2. Identifying Subsequent Therapies in Patients with Advanced Non-Small Cell Lung Cancer and Factors Associated with Overall Survival;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2016-09-25

3. Efficacy of First-line Chemotherapy Affects the Second-Line Setting Response in Patients with Advanced Non-Small Cell Lung Cancer;Asian Pacific Journal of Cancer Prevention;2014-08-30

4. Comparison of the use of Platinum-Based Combination in the First and Second Line Treatment of Non-Small Cell Lung Cancer;Annals of Clinical and Analytical Medicine;2013

5. Gemcitabine Plus Paclitaxel as Second-line Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer;Asian Pacific Journal of Cancer Prevention;2012-10-31